Related Experiment Video
Updated: Oct 17, 2025

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
A reflective process led by a family physician to develop a renal-protection surveillance tool for HIV patients newly
Junaid Omar1, Izak Loftus, Nabeelah Vallie
1Vanguard Community Health Centre, Western Cape Department of Health, Cape Town. juniadomar@live.com.
Abstract:
A group of Vanguard Community Health Centre doctors embarked on a Health System's Improvement (HSI) project with the aim of reducing harm to renal function in patients who were either commenced on or switched to a dolutegravir (DTG)-based antiretroviral therapy (ART) regimen since 2019, when the usual monitoring and evaluation of ART-regimen switches were disrupted by the coronavirus disease 2019 (COVID-19) pandemic. This intended harm-reduction exercise, involving a reflective process that was facilitated by the family physician, led to the development of a Vanguard Renal Protection Surveillance tool, which is now used at Vanguard to detect and prevent renal decline.
Related Concept Videos
Therapeutic Drug Monitoring: Affecting Factors
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Pharmacokinetics in Pediatric Patients: Drug Excretion
Chronic Kidney Disease III: Interprofessional Care
Kidney Transplant III: Nursing Management

